Company
Company

Relevant Interviews, Webinar and Trial Updates posted by CRISPR Medicine News.

Always stay updated with the free CMN Newsletter.

Sherlock Biosciences

Main focus: Development of novel Cas-enzymes for diagnostics

Company stage: Commercial (diagnostics), pre-clinical (therapeutics)

Diseases: COVID-19 (diagnostics)

Genome editing tool: CRISPR-Cas12a, CRISPR-Cas12b, CRISPR-Cas13.

Funding stage: Private

Location: Cambridge, MA, USA

Website: https://sherlock.bio/

Partners: Tolo Biotech

Sherlock Biosciences is a CRISPR diagnostics company. The company deploys its SHERLOCK™- and INSPECTR™-platforms that are based on novel Cas-enzymes, and so far, it has commercialised a novel CRISPR-based SARS-CoV-2 detection kit. The company is co-founded by Feng Zhang, who also co-founded Arbor Biotechnologies and Beam Therapeutics.

Tags

HashtagSherlock Biosciences, Inc.

Company: Sherlock Biosciences
close
Search CRISPR Medicine